Clinical Trial Update: Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares prostatic artery embolization to 532 nm green light photoselective vaporization of the prostate (PVP) for catheterized patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Urinary Retention

Snippet

Sponsor: Royal Victoria Hospital, Canada | Conditions: Benign Prostate Hyperplasia, Urinary Retention | Phase 4 | Status: UNKNOWN